Healia Clinical Trials Information Database

Preventing Heart Disease in Underserved Patients

The study will evaluate the impact of an internet based telemedicine system on cardiovascular risk profile of underserved patient populations. It is our hypothesis that a treatment plan and frequent communication via an internet based Telemedicine system will improve the cardiovascular risk profile of underserved patient populations at increased risk for cardiovascular disease. Our primary endpoint is a reduction over one year in the 10-year CVD risk score (ATP III risk model).

Description

The Insight Telehealth system (ITSMyHealthfile) is a disease-managment interactive health care delivery system. Patients access the system through a special Web site using a password. The system prompts the patient to enter their weight, blood pressure and heart rate and there is a text box available for unstructed comments.

Patients will be randomized to either the telemedicine group or usual care group (controls). Individuals in the telemedicine group will be asked to transmit their health status weekly. Both groups will be followed for one year with quarterly visits.

Patients of either sex, of any ethnic background or race, between 22 and 85years of age, who have a 10% or greater 10-year risk of CVD based on the Framingham risk score, and risk factors that if properly treated would reduced the risk by 5% or greater will be eligible for the study.

Additional criteria

  • literate

  • telephone access

  • ablility to utilize the Internet and telemedicine system (after training) Primary Outcome Reduction in Framingham risk index

Status: Completed (N/A). Started on July 1st, 2004. Ended on February 1st, 2007.

Enrollment: 465 subjects

Study Type: Interventional

Study Design:

  • Prevention
  • Randomized
  • Open Label
  • Active Control
  • Parallel Assignment
  • Efficacy Study

Conditions:

Interventions:

  • Behavioral: telemedicine

Eligibility

Inclusion Criteria:

  • Framingham risk score equal to or greater than 10%

  • literacy

  • 22 -85 years of age

  • access to phone

    • ability to use Internet and system following training

Exclusion Criteria:

  • Class 3 and 4 heart failure

  • ESRD

  • stroke with residual disability or dementia

  • unable to read or write

Gender

Both

Mininum Age

22 Years

Maximum Age

85 Years

Healthy Volunteers

No


Resources

Source: Temple University

Authority: United States: Institutional Review Board

Locations

  • Temple University Hospital
    Philadelphia
    Pennsylvania
    19140
    United States
  • Temple University Hosptial
    Philadelphia
    Pennsylvania
    19140
    United States
  • Geisinger Medical Center
    Danville
    Pennsylvania
    17822
    United States

Officials

  • Alfred A Bove, MD, PhD (Principal Investigator, Temple University)

Sponsors

  • Temple University (Lead Sponsor)

  • Geisinger Medical Center (Collaborator)

  • Insight Telehealth Systems (Collaborator)

  • Pennsylvania Department of Health (Collaborator)

References

None.

Links

None.


Date Verified
October 1st, 2008
First Received
October 22nd, 2008
Last Changed
October 22nd, 2008

Information obtained from ClinicalTrials.gov on October 23, 2008. Link to the current ClinicalTrials.gov record.


All data in the Healia Clinical Trials Information Database and content displayed by the Healia Clinical Trials Search Engine are licensed from the National Institutes of Health (National Library of Medicine), which collects and maintains the data.

The Healia Clinical Trials Search Engine searches the data set at clinicaltrials.gov, providing up-to-date information about current clinical trials. In the Healia Clinical Trials Database you can find information on new experimental drugs, medical devices, and other types of treatments for all types of diseases. Each clinical trial description includes information about the phase of the trial (phase I, phase II, or phase III), the trial’s methods, such as whether it is a randomized, placebo controlled, double blind study, and the status of the trial including whether or not the trial is currently enrolling new participants.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.